首页 | 本学科首页   官方微博 | 高级检索  
检索        

非体外循环心脏手术凝血酶和血小板的激活及乌司他丁的影响
引用本文:王古岩,吉冰洋,刘宁宁,昌克勤,王越夫,何爱霞,李立环.非体外循环心脏手术凝血酶和血小板的激活及乌司他丁的影响[J].中国体外循环杂志,2010,8(2):100-102,121.
作者姓名:王古岩  吉冰洋  刘宁宁  昌克勤  王越夫  何爱霞  李立环
作者单位:1. 中国医学科学院,北京协和医学院心血管病研究所阜外心血管病医院麻醉科,北京,100037
2. 首都医科大学附属安贞医院体外循环科
3. 首都医科大学附属安贞医院心外科
摘    要:目的观察非体外循环冠状动脉旁路移植术(OPCABG)患者围术期凝血酶和血小板的激活情况及乌司他丁对此的影响。方法采取随机、双盲、对照的方法将40例OPCABG患者分为对照组(C组)和乌司他丁组(U组),每组20例。U组:麻醉诱导后开始恒速静脉泵入6 000 U/kg的乌司他丁,30 min内输完,然后以1 000 U/(kg.h)的速度持续静脉泵入至手术结束。C组:给予相同容积的生理盐水。分别在切皮前(T1)、术后即刻(T2)、术后2 h(T3)、6 h(T4)、术后18 h(T5)测定血小板α颗粒膜蛋白(GMP-140)和尿纤维蛋白肽(uFPA)浓度,并记录患者的术后24 h胸液量等临床资料。结果与T1比较,两组在T2和T3时点uFPA浓度和在T3、T4和T5时点GMP-140浓度均显著升高(P0.05);组间比较差异均无统计学意义(P0.05)。结论 OPCABG患者围术期存在凝血酶和血小板激活,乌司他丁对此无明确保护作用。

关 键 词:非体外循环  冠状动脉旁路移植术  胰蛋白酶抑制剂  纤维蛋白肽A  血小板α颗粒膜蛋白

Effect of ulinastatin on thrombin and platelet activation in the patients during off-pump coronary artery bypass graft surgery
Wang Gu-yan,Ji Bing-yang,Liu Ning-ning,Chang Ke-qin,Wang Yue-fu,He Ai-xia,Li Li-huan.Effect of ulinastatin on thrombin and platelet activation in the patients during off-pump coronary artery bypass graft surgery[J].Chinese Journal of Extracorporeal Circulation,2010,8(2):100-102,121.
Authors:Wang Gu-yan  Ji Bing-yang  Liu Ning-ning  Chang Ke-qin  Wang Yue-fu  He Ai-xia  Li Li-huan
Institution:(Department of Anesthesiology,Cardiovascular Institute and FuUai Hospital,CAMS&PUMC,Beijing 100037,China )
Abstract:OBJECTIVE To investigate the effects of ulinastatin on perioperative thrombin and platelet activation in the patients undergoing off-pump coronary artery bypass graft surgery(OPCABG).METHODS Forty low risk patients undergoing OPCABG were divided in a double-blind and randomized fashion into 2 groups(n=20 each): control group(C) and ulinastatin group(U).Anesthesia was induced with midazolam 0.1mg/kg,fentanyl 10-20μg/kg and pancuronium 0.1 mg/kg,and maintained with 1%-2% isoflurane and intermittent IV boluses of fentanyl and pancuronium.Ulinastatin 6000 U/kg in 50 ml of normal saline was infused intravenously over 30 min after induction of anesthesia followed by continuous infusion of ulinastatin at 1000 U/(kg·h) until the end of the operation.In group C,the equal volume of normal saline was infused instead of ulinastatin.Venous blood and urine samples were taken before operation(T1),at the end of operation(T2),and 2 h(T3),6 h(T4),and 18 h(T5) after the operation for determination of plasma α-granule membrane protein-140(GMP-140) and urine fibrinopeptide A(uFPA) concentration.RESULTS Plasma concentration of GMP-140 at T3-5 and uFPA concentration at T2,3 were significantly increased compared with baseline value at T1 in both groups,but there was no significant difference between 2 groups.CONCLUSION Current data suggested that Ulinastatin cannot inhibit the thrombin and platelet activating during and after operation in the patients undergoing OPCABG.
Keywords:Off-pump  Coronary artery bypass graft  Trypsin inhibitors  Fibrinopeptide A  α-granule membrane protein-140
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号